Jasmin Moshfegh on the economics of healthcare innovation

Dr Moshfegh discusses how her research in precision medicine is aimed at reducing health inequalities

2 minute read
Headshot of a woman with curly hair standing in front of a beige background. Jasmin Moshfegh - New academic - 2025-26
Main image: Jasmin Moshfegh

Understanding how new medical technologies diffuse through health systems, especially including who gets access to them, is central to Dr Jasmin Moshfegh’s research. Joining Imperial Business School in 2025 as Assistant Professor of Economics & Public Policy, she brings a research agenda that sits at the intersection of health economics and healthcare innovation. 

How precision medicine and health equity intersect 

Her work examines the causes and consequences of healthcare innovation, with a focus on precision medicine, AI and assisted reproductive technologies. By combining quasi-experimental methods with large administrative datasets and cancer registries, she sheds light on how institutional and policy choices shape both efficiency and equity in healthcare delivery.  

Her job market paper, supported by the US Agency for Healthcare Research and Quality (AHRQ), studies the adoption of genomic testing in breast cancer care—showing that while precision medicine can reduce unnecessary treatments, it may also exacerbate racial disparities. 

Dr Moshfegh completed her PhD in Health Policy (Economics) at Stanford University, where she was also a T32 Fellow and R36 awardee from AHRQ. She went on to hold a Postdoctoral Fellowship at Stanford, alongside appointments as a Fellow at the US Department of Veterans Affairs and  the National Cancer Institute at the National Institutes of Health. Her research has been supported by grants from the Agency for Healthcare Research and Quality, the SIEPR George P. Shultz Fund and the Sweden-America Foundation. 

Extending research into new frontiers 

Dr Moshfegh studies the causes and consequences of healthcare innovation, with a particular focus on information technologies. She is extending her work to explore the impact of next-generation diabetes drugs in the US Veterans population and the role of AI tools in improving women’s health in India. 

Reflecting on her move to London, she said: “What excites me most about joining Imperial is the opportunity to be part of a department and institution that sits at the intersection of cutting-edge research, interdisciplinary collaboration, and real-world impact. Imperial’s unique ecosystem brings these disciplines together in a way that few other places can.” 

Meet the author

  • Shamita Harsh

    About Shamita Harsh

    Communications Officer
    Shamita is Senior Digital Communications Officer for the Marketing & Communications function at Imperial Business School, where she is responsible for content strategy and storytelling around faculty research. She is responsible for developing and curating content across the School’s digital platforms, including IB Knowledge and thought leadership for global audiences. She oversees news and events coverage of interdisciplinary research and Imperial-wide initiatives to elevate the Business School’s academic voice. Prior to this, she worked at Imperial’s Grantham Institute, as the Communications and EDI Officer contributing to climate and sustainability communications for the Better Futures Retrofit Accelerator.